Benzinga | Apr 13, 2021 06:39AM EDT

Piper Sandler Maintains Overweight on LivaNova, Raises Price Target to $92

Piper Sandler analyst Adam Maeder maintains LivaNova (NASDAQ:LIVN) with a Overweight and raises the price target from $81 to $92.